Cargando…
Wearable cardioverter defibrillator: Bridge or alternative to implantation?
The implantable cardioverter-defibrillator (ICD) is effective to prevent sudden cardiac death (SCD) in selected patients with heart disease known to be at high risk for ventricular arrhythmia. Nevertheless, this invasive and definitive therapy is not indicated in patients with potentially transient...
Autores principales: | Barraud, Jeremie, Cautela, Jennifer, Orabona, Morgane, Pinto, Johan, Missenard, Olivier, Laine, Marc, Thuny, Franck, Paganelli, Franck, Bonello, Laurent, Peyrol, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491470/ https://www.ncbi.nlm.nih.gov/pubmed/28706588 http://dx.doi.org/10.4330/wjc.v9.i6.531 |
Ejemplares similares
-
Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis
por: Cautela, Jennifer, et al.
Publicado: (2020) -
Bridge to avoid ICD implantation with wearable cardioverter defibrillators
por: Zoppo, Franco, et al.
Publicado: (2020) -
High incidence of atrial fibrillation in patients treated with ibrutinib
por: Baptiste, Florian, et al.
Publicado: (2019) -
Antitachycardia pacing programming in implantable cardioverter defibrillator: A systematic review
por: De Maria, Elia, et al.
Publicado: (2017) -
Wearable cardioverter-defibrillator as bridging to ICD in pediatric hypertrophic cardiomyopathy with myocardial bridging – a case report
por: Kurath-Koller, Stefan, et al.
Publicado: (2020)